0
Articles |

Lung Cancer Over 17 Years of Aspen Lung Conferences*

York E. Miller, MD; Robert L. Keith, MD, FCCP
Author and Funding Information

*From the Division of Pulmonary Sciences and Critical Care Medicine (Drs. Miller and Keith), Denver Veterans Affairs Medical Center, Denver, CO; and the University of Colorado Comprehensive Cancer Center (Dr. Keith), University of Colorado Health Sciences Center, Boulder, CO.

Correspondence to: York E. Miller, MD, Pulmonary 111A, Denver Veterans Affairs Medical Center, 1055 Clermont St, Denver, CO 80220-3808; e-mail york.miller@uchsc.edu



Chest. 2004;125(5_suppl):79S. doi:10.1378/chest.125.5_suppl.79S
Text Size: A A A
Published online

Extract

This year’s Thomas L. Petty Aspen Lung Conference represents the second time that lung cancer has been the topic in the conference’s 45-year history. Seventeen years ago, Charles Scoggin chaired an Aspen Lung Conference on the Molecular and Cellular Biology of Lung Cancer. At that time, several oncogenes had been identified, but no tumor suppressor genes had yet been characterized. The Rb gene was first cloned later that year, and p53 was thought to be a tumor-associated antigen or an oncogene, not a tumor suppressor. No presenters discussed specific oncogenes in lung cancer, although there was a talk on alterations in DNA methylation. The conference focused on the general principles of cancer biology, but the specific mutations and alterations in gene expression that underlie the neoplastic process were largely unknown. Few of the participants were pulmonologists, and the research was not yet at the stage at which it could be readily translated to the clinical arena.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543